Peripheral T-cell Lymphomas: Considerations for Frontline Therapies

Peripheral T-cell lymphomas (PTCL) continue to present a significant clinical challenge both at the time of initial diagnosis and during the relapse. A proportion of patients with PTCL diagnoses can achieve cure or long-term disease control; hence, in the majority of cases, the intent of initial therapy is curative. However, given the advanced age at the time of diagnosis in the majority of PTCL cases, palliative intent frontline therapy should also be explored for a sizable proportion of patients.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research